by Matthew Johnson | Mar 7, 2025 | PTAB News, PTAB Trial Basics, Standing
By Ellen Geyer and Matt Johnson – The Federal Circuit rejected a recent argument that the PTAB does not have inter partes review (IPR) jurisdiction over expired patents. Because even expired patents involve the grant of public rights, the court explained that...
by Matthew Johnson | Mar 3, 2025 | PTAB News, PTAB Trial Basics, Trial Institution
By Ashvi Patel and Matt Johnson – On Friday, the USPTO rescinded its June 21, 2022, guidance memorandum entitled “Interim Procedure for Discretionary Denials in AIA Post-Grant Proceedings with Parallel District Court Litigation.” That memorandum discussed...
by Matthew Johnson | Feb 25, 2025 | PTAB News, Request for Reconsideration
By Sabrina Bellantoni and Matt Johnson – Recently, a Director Review was granted where Director Vidal vacated the Patent Trial and Appeals Board’s (“PTAB”) Final Written Decision and remanded back to the PTAB for further consideration of enablement. Duration...
by Matthew Johnson | Feb 11, 2025 | Federal Circuit, PTAB News
By Parth Matalia and Matt Johnson – Palo Alto Networks (PAN) filed a petition for inter partes review of Centripetal Networks’ patent—U.S. Patent No. 10,530,903—which is directed to a computing system for correlating packets in communication networks with a...
by Matthew Johnson | Feb 6, 2025 | Prior Art Issues, PTAB News
By Raffaella Faraoni and Matt Johnson – The Federal Circuit affirmed six PTAB decisions that held unpatentable as obvious 79 claims of three Cytiva Bioprocess (“Cytiva”) challenged patents and reversed the PTAB decision upholding four claims. JSR Corp. (“JSR”)...
